Adult Vaccines Market, By Vaccines (Influenza, Tetanus, Diphtheria, Pertussis (Td/Tdap), Varicella, Human Papillomavirus, Zoster, Measles, Mumps, Rubella (MMR), Pneumococcal, Hepatitis, Others), By Vaccine Type (Monovalent and Multivalent), By Technology

Adult Vaccines Market, By Vaccines (Influenza, Tetanus, Diphtheria, Pertussis (Td/Tdap), Varicella, Human Papillomavirus, Zoster, Measles, Mumps, Rubella (MMR), Pneumococcal, Hepatitis, Others), By Vaccine Type (Monovalent and Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness about available vaccines and their benefits for adults has prompted more individuals to get vaccinated. Moreover, expansion of indications for existing adult vaccines and development of new formulations have strengthened prevention against various diseases affecting the adult population worldwide. However, high development costs and lack of adequate vaccination infrastructure in developing nations can hamper the market growth.

Market Dynamics:

Global adult vaccines market growth is driven by rising prevalence of diseases such as influenza, meningococcal meningitis, pneumococcal infection, and others among adults. According to the World Health Organization, seasonal influenza results in severe illness in around 3-5 million cases and 290,000-650,000 respiratory deaths globally every year. Increasing healthcare expenditures, favorable government support through vaccination programs and introduction of novel vaccines can drive the market growth. However, low awareness in developing countries, high R&D costs associated with development of new vaccines and storage requirements can hamper the market growth. Development of thermostable vaccines without refrigeration needs and combined adult vaccine formulations can offer opportunities for market players.

Key Features of the Study:
  • This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global adult vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Novavax, Pfizer, and CSL Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market
Detailed Segmentation-
  • By Vaccines
  • Influenza
  • Tetanus, Diphtheria, Pertussis (Td/Tdap)
  • Varicella
  • Human Papillomavirus
  • Zoster
  • Measles, Mumps, Rubella (MMR)
  • Pneumococcal
  • Hepatitis
  • Others
  • By Vaccine Type
  • Monovalent
  • Multivalent
  • By Technology
  • Live Attenuated Vaccines
  • Inactivated Viral/Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi Pasteur
  • AstraZeneca
  • Johnson & Johnson
  • Novavax, Inc.
  • Moderna, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Bavarian Nordic
  • Dynavax Technologies Corporation
  • BioNTech S
  • Emergent BioSolutions Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Sinovac Biotech Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Vaccines
Market Snapshot, By Vaccine Type
Market Snapshot, By Technology
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Adult Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Adult Vaccines Market, By Vaccines, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Influenza
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Varicella
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Human Papillomavirus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Zoster
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Measles, Mumps, Rubella (MMR)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Pneumococcal
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Hepatitis
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Adult Vaccines Market, By Vaccine Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Monovalent
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Multivalent
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Adult Vaccines Market, By Technology, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Live Attenuated Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Inactivated Viral/Bacterial Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Toxoid Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Recombinant Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Conjugate Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Adult Vaccines Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
GlaxoSmithKline plc
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck & Co., Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Sanofi Pasteur
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
AstraZeneca
Johnson & Johnson
Novavax, Inc.
Moderna, Inc.
Inovio Pharmaceuticals, Inc.
Bavarian Nordic
Dynavax Technologies Corporation
BioNTech S
Emergent BioSolutions Inc.
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Sinovac Biotech Ltd.
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on Adult Vaccines Market” - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings